The U.S. Food and Drug Administration approved Crinetics Pharmaceuticals' drug to treat a rare hormonal disorder on Thursday, making it the first once-daily oral pill available for patients in the ...

Crinetics Pharmaceuticals won FDA approval for a drug to treat acromegaly, a rare and debilitating hormonal disorder.

Men with prostate cancer can safely exercise, benefiting from reduced treatment side effects, improved mental health, and ...

After nearly two decades in the endocrine scene, Crinetics is making its commercial debut with the approval of a ...

Firefighters face health risks from chronic cortisol exposure. Effective stress management is crucial for well-being and ...

Exercise affects testosterone in other ways, too, says Brian McNeil, M.D., chief of urology at SUNY Downstate Health Sciences University. When you work out, you’ll improve your overall health and ...

Also known as androgenetic alopecia, female pattern hair loss (FPHL) will affect 40 percent of women by age 50, according to the Journal of the American Academy of Dermatology. This chronic and slow ...

The global rise in obesity is staggering. Obesity has doubled in over 70 nations within a span of a mere four decades.

Alcohol, while not directly causing hair to fall out, can cause your body to absorb fewer nutrients. It can also put stress ...

Takeda offers a compelling investment case with six late-stage therapies targeting $20 billion in peak sales by 2030-31.

On Wednesday, the World Anti-Doping Agency (WADA) released its list of prohibted substances and methods for 2026.